IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 40 filers reported holding IKENA ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $857,392 | -26.3% | 198,012 | +11.7% | 0.00% | – |
| Q2 2023 | $1,163,376 | +995.2% | 177,344 | +476.0% | 0.00% | – |
| Q1 2023 | $106,225 | +47.3% | 30,790 | +13.5% | 0.00% | – |
| Q4 2022 | $72,137 | -25.6% | 27,119 | -0.4% | 0.00% | – |
| Q3 2022 | $97,000 | +40.6% | 27,234 | +76.5% | 0.00% | – |
| Q2 2022 | $69,000 | -94.4% | 15,434 | -92.3% | 0.00% | – |
| Q1 2022 | $1,228,000 | -53.0% | 201,180 | -3.3% | 0.00% | – |
| Q4 2021 | $2,610,000 | +125.4% | 208,065 | +126.8% | 0.00% | – |
| Q3 2021 | $1,158,000 | -3.0% | 91,757 | +7.9% | 0.00% | – |
| Q2 2021 | $1,194,000 | – | 85,062 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,018,178 | $30,611,000 | 3.87% |
| Omega Fund Management, LLC | 2,249,123 | $13,720,000 | 2.81% |
| CHI Advisors LLC | 814,755 | $4,970,000 | 2.11% |
| BVF INC/IL | 2,501,571 | $15,260,000 | 0.61% |
| Artal Group S.A. | 1,549,513 | $9,452,000 | 0.40% |
| Orbimed Advisors | 2,933,941 | $17,897,000 | 0.29% |
| Logos Global Management LP | 178,281 | $1,088,000 | 0.14% |
| HealthCor Management, L.P. | 287,621 | $1,754,000 | 0.12% |
| FARALLON CAPITAL MANAGEMENT LLC | 792,077 | $4,832,000 | 0.02% |
| Point72 Asset Management, L.P. | 348,696 | $2,127,000 | 0.01% |